Anti-MSLN CAR T cells in this trial also carry a suicide switch based on the iCasp9 cell-suicide system [43], which can be activated in case of severe ‘on target/off tumor’ toxicities (Fig. 2e). The gene discussed is MSLN; the disease is neoplasm.